However, its sensitivity may be insufficient to reliably measure GFAP in the blood, of which concentrations in most patients with neurological disorders range from 10−14 to 10−10 M (0.5–5,000 pg/mL) (59–64). This evidence concerns the gene GFAP and nervous system disorder.